Group One Trading
CGON icon

Group One Trading’s CG Oncology CGON Stock Holding History

Group One Trading’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,435
Closed -$93.8K – 7664
2026
Q1 		$97.1K Buy
+1,435
New +$81.3K ﹤0.01% 4758
2025
Q3 		– Sell
-3,985
Closed -$116K – 8475
2025
Q2 		$104K Buy
+3,985
New +$96K ﹤0.01% 4928

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Group One Trading's CGON Position: Q2 2026 in Review

Group One Trading sold out of CG Oncology (CGON) in Q2 2026, closing a stake of 1,435 shares — an estimated $93.8K sold.

Group One Trading first reported a position in CGON in Q2 2025 and held it in 2 quarters. The position peaked at $104K in Q2 2025. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Group One Trading reported no remaining CG Oncology position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,435 CG Oncology shares in Q2 2026, an estimated $93.8K.
  • Group One Trading first reported a position in CG Oncology in Q2 2025 and held it in 2 quarters.
  • Group One Trading's CG Oncology position peaked at $104K in Q2 2025.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.